Shane Madden
Chief Executive Officer
Replay available
Hydreight Technologies Inc. (TSXV: NURS) Q2 2025 earnings conference call, held 2025-08-29. Replay captured from the company's public earnings webcast.

Chief Executive Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Hydreight Technologies Inc.
WEBVTT 00:00:00.031 -- 00:00:03.154 Good afternoon, everyone. Thank you so much for joining us. 00:00:03.154 -- 00:00:05.476 This is Hydrate Technologies 00:00:05.476 -- 00:00:11.262 Q2 investor webinar. We're going to go over the earnings today that were just released. 00:00:11.262 -- 00:00:15.787 So we'll just give it a few moments while we let everyone join as I see people still 00:00:15.787 -- 00:00:19.631 joining in the weight room. If you do have any questions, please don't hesitate to put 00:00:19.631 -- 00:00:24.616 them in that Q&A section. And we are going to be keeping this webinar to that 30 minutes. 00:00:24.616 -- 00:00:26.137 So 00:00:26.137 -- 00:00:28.302 Yeah, we're going to get through it pretty fast. 00:00:28.302 -- 00:00:32.591 But if you do have additional questions that we don't get to, please send them to our 00:00:32.591 -- 00:00:35.978 investor relations email at ir.hydrate.com. 00:00:35.978 -- 00:00:39.205 I'll also put that in the chat section for you. 00:00:39.205 -- 00:00:43.655 And just a reminder that we will be going over Just 00:00:43.655 -- 00:00:47.724 a reminder to take a look at our forward-looking statement as we will like to remind 00:00:47.724 -- 00:00:51.453 everyone that today's presentation will include forward-looking statements. 00:00:51.453 -- 00:00:55.824 The statements are based on current expectations and assumptions and are subject to a 00:00:55.824 -- 00:01:01.393 number of risks and uncertainties. that could cause actual results to differ materially 00:01:01.393 -- 00:01:05.298 from those projected. So forward-looking statements may include but are not limited to 00:01:05.298 -- 00:01:09.422 statements about our growth strategies, product development, financial performance, regulatory 00:01:09.422 -- 00:01:14.549 o...